logo

Home

|

Products

|

9789356962026

Image of - Treatment of Cystic Fibrosis and Other Rare Lung Diseases | Hardcover
Treatment of Cystic Fibrosis and Other Rare Lung Diseases | Hardcover

Treatment of Cystic Fibrosis and Other Rare Lung Diseases | Hardcover

by Azuma

This volume describes the pathogenesis and pathophysiology of several pulmonary diseases as well as their treatment. It also discusses the underlying genetic and molecular biological basis, which opens the way for new treatments for these conditions.It focuses on the treatment of cystic fibrosis including CFTR (cystic fibrosis transmembrane-conductance regulator) modulator therapies, drug therapies that augment airway surface liquid as well as anti-inflammatory and anti-infective therapies. Further topics include long-term, low-dose macrolide therapy for diffuse panbronchiolitis; novel agents for previously untreatable idiopathic pulmonary fibrosis; possible new treatments for pulmonary alveolar proteinosis (PAP); and multiple novel therapeutic targets for treating lymphangiomyomatosis. Research into these conditions has led to major advances in our understanding of the underlying genetic and molecular basis of this disease, and to dramatic improvements in survival and quality of life for affected individuals.

Highlights

  • binding-icon

    9783034809757

    ISBN:

  • binding-icon

    Azuma

    Author:

  • binding-icon

    263

    Pages:

  • binding-icon

    210 gm

    Weight:

  • langauage-icon

    English

    Language:

  • date-icon

    2017

    Year:

  • edition-icon

    1st Edition

    Edition:

  • binding-icon

    Hardcover

    Binding:

₹12731

₹14146

This volume describes the pathogenesis and pathophysiology of several pulmonary diseases as well as their treatment. It also discusses the underlying genetic and molecular biological basis, which opens the way for new treatments for these conditions.It focuses on the treatment of cystic fibrosis including CFTR (cystic fibrosis transmembrane-conductance regulator) modulator therapies, drug therapies that augment airway surface liquid as well as anti-inflammatory and anti-infective therapies. Further topics include long-term, low-dose macrolide therapy for diffuse panbronchiolitis; novel agents for previously untreatable idiopathic pulmonary fibrosis; possible new treatments for pulmonary alveolar proteinosis (PAP); and multiple novel therapeutic targets for treating lymphangiomyomatosis. Research into these conditions has led to major advances in our understanding of the underlying genetic and molecular basis of this disease, and to dramatic improvements in survival and quality of life for affected individuals.

Loading...

Online store of medical books

Discover a comprehensive range of medical books at our online store. From anatomy and physiology to the latest clinical guidelines, we've got you covered.

Trusted by students, educators, and healthcare professionals worldwide. Browse top publishers and expert-authored titles in every medical specialty. Enjoy fast shipping, secure payments, and easy returns. Your one-stop destination for quality medical knowledge at your fingertips.

Whether you're preparing for exams or expanding your clinical expertise, our curated collection ensures you have the right resources at hand. Dive into detailed illustrations, case studies, and up-to-date research that enhance your understanding and practical skills.

We regularly update our inventory to include the latest editions and newly released titles, helping you stay current in the ever-evolving medical field. Our advanced search and filtering tools make finding the perfect book quick and hassle-free.

Join our community of lifelong learners and medical enthusiasts. Sign up for exclusive discounts, early access to new arrivals, and personalized book recommendations tailored to your professional interests.